Cross-state Collaboration Leads to National Excellence

 Partners

Research being done in the labs at the Center of Excellence in Bioinformatics & Life Sciences.

Corporate Partners

BIG partners with companies, providing them access to expertise, research capabilities and supercomputing resources. This boosts the creation of new approaches to personalized medicine, diagnostics and technologies created in Western New York. 

Circuit Clinical

Circuit Clinical logo

Circuit Clinical personalizes medicine by bringing studies to the physicians that patients know and trust. The company streamlines the process while removing cost for physicians in order to bring new medical solutions to patients.

As part of its engagement with BIG, Circuit Clinical will expand its technology platform and bring software development jobs to Buffalo. 

Garwood Medical Devices

Garwood Medical Devices logo

Garwood Medical is an advanced medical device company whose products will positively enhance clinical outcomes related to infection. Through advanced technology and novel designs, Garwood Medical is committed to disrupt the wound care and perio-prosthetic market by advancing infection control through innovation.

A strategic partnership with BIG provides the company with a state of the art research and development site and a robust university engineering team. This public-private partnership will drive Garwood’s and UB’s technologies through development, by performing all aspects of research, device modeling, rational product design and prototyping, focusing on verifications, validations and characterizations of the applications and imbedded technologies.

Tactiva Therapeutics 

Garwood Medical Devices logo

Tactiva is a development stage immuno-oncology company with a unique approach to adoptive T-cell therapy. Tactiva's dual enhanced adoptive cell therapy (DEACT™) platform, consists of engineered CD4/CD8 cells which generate a durable supply of CD4 cells with direct anti-tumor activity as well as sustained helper function to CD8 T cell derived TCR-transduced effector T cells.  Tactiva Therapeutics is working to develop the next generation of cancer immunotherapies by utilizing a new approach to cell therapy. This type of personalized cancer treatment enhances the patient's immune system ability to tackle the disease.

Tactiva Therapeutics has been a partner to the University at Buffalo’s since January 2017 when it colocated at the New York State Center of Excellence in Bioinformatics and Life Sciences on the Buffalo Niagara Medical Campus.

Through the partnership with the University at Buffalo, Tactiva Therapeutics has received funding support from the UB Center for Advanced Technology in Big Data and Health Sciences that enabled a collaboration with UB’s Genomics and Bioinformatics Core, infrastructure that was funded by BIG in support of Tactiva’s discovery efforts.

The partnership with BIG provides Tactiva Therapeutics with access to equipment for their preclinical development of Tactiva’s DEACTTM platform.

Network Partners

The Buffalo Institute for Genomics & Data Analytics (BIG) partners with institutions and facilities across New York State in leading genomics research and technology.

Empire Genomics

Empire Genomics logo

Created in 2006 by University at Buffalo faculty member Dr. Norma Jean Nowak, a recognized leader in the field of genomics, from research started at Roswell Park Cancer Institute.  The laboratory has a strong track record in the development of high throughput technologies to enable genome-wide analyses aimed at determining the underlying mechanisms for diseases. Having played a fundamental role in the Human Genome Project and created the foundational Bacterial Artificial Chromosomes, which served as the basis for sequencing the genome, Empire Genomics developed significant expertise in genomic research.

New York Genome Center

logo for New York Genome Center

The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives.  As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease.  NYGC’s Integrated Genomics include experimental design assistance, sample quality control processes, library preparation, sequencing, extensive data quality control, bioinformatics and data storage.

NYSERNet

logo for NYSERNet

NYSERNet is a private not-for-profit corporation created to foster science and education in New York State. Its mission is to advance network technology and related applications to satisfy needs common to the institutions comprising New York State's research and education community, providing a forum for exploration of the opportunities and challenges these innovations present.  An Internet pioneer, NYSERNet has delivered next-generation Internet services to New York State's research and education community for 30 years.